ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
Author(s): Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavilio F, Traversari C, Bordignon C
Source: SCIENCE    Volume: 276    Issue: 5319    Pages: 1719-1724    Published: JUN 13 1997  
Times Cited: 615     References: 41     
Abstract: In allogeneic bone marrow transplantation (allo-BMT), donor lymphocytes play a central therapeutic role in both graft-versus-leukemia (GvL) and immune reconstitution. However, their use is limited by the risk of severe graft-versus-host disease (GVHD). Eight patients who relapsed or developed Epstein-Barr virus-induced lymphoma after T cell-depleted BMT were then treated with donor lymphocytes transduced with the herpes simplex virus thymidine kinase (HSV-TK) suicide gene. The transduced lymphocytes survived for up to 12 months, resulting in antitumor activity in five patients. Three patients developed GVHD, which could be effectively controlled by ganciclovir-induced elimination of the transduced cells. These data show that genetic manipulation of donor lymphocytes may increase the efficacy and safety of allo-BMT and expand its application to a larger number of patients.
Document Type: Article
Language: English
Addresses:
1. IST SCI SAN RAFFAELE, TELETHON INST GENE THERAPY, I-20132 MILAN, ITALY
2. MOLMED SPA, I-20132 MILAN, ITALY
3. IST SCI SAN RAFFAELE, DEPT PATHOL, I-20132 MILAN, ITALY
Publisher: AMER ASSOC ADVANCEMENT SCIENCE, 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005
Subject Category: Multidisciplinary Sciences
IDS Number: XD947
ISSN: 0036-8075
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo